Ginkgo Bioworks acquires AgBiome’s platform assets, terms not disclosed

Ginkgo Bioworks announced the acquisition of AgBiome’s platform assets, including over 115,000 fully sequenced and isolated strains, over 500M unique gene sequences, and relevant functional data and metadata, as well as AgBiome’s development pipeline. These assets will be integrated into Ginkgo Ag Biologicals Services, established with the acquisition of a Bayer agricultural biologicals R&D facility in 2022, and will expand Ginkgo’s proprietary unified metagenomics database. Combined, this creates one of the deepest and most advanced ag biological discovery and development platforms as well as a rich resource for the development of AI models for biological R&D.